LEVOSIMENDAN Labatec conc perf 12.5 mg/5ml flac
7680695510010
CH-69551
C01CX08
02.05.2.
1 / 3
google
Details
- GTIN
- 7680695510010
- Pharmacode
- -
- Product number
- 6955101
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- levosimendanum 12.5 mg, povidonum K 12, ethanolum anhydricum 3.945 g, acidum citricum, ad solutionem pro 5 ml, corresp. ethanolum 99 % V/V.
Articles (1)
Levosimendan Labatec 12.5 mg/5 ml, solution à diluer pour perfusion
Lösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
levosimendanum
|
12.5 MG | Substance | Wirkstoff (Principe actif) |
|
povidonum K 12
|
- | Substance | HNIDK |
|
ethanolum anhydricum
|
3.945 G | Substance | HBESI |
|
acidum citricum
|
- | Substance | HNIDK |
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 69551
- Drug name
- Levosimendan Labatec, solution à diluer pour perfusion
- Galenic form
- KOINF
- ATC Code
- C01CX08
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 10/07/2024
- Authorization expiration date
- 09/07/2029
- IT number
- 02.05.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LEVOSIMENDAN Labatec conc perf 12.5 mg/5ml flac
- Description (DE)
- LEVOSIMENDAN Labatec 12.5 mg/5ml Inf Konz Durchstf
- Market launch
- 21/04/2026
- Narcotic (BTM)
- No